Café

© 2026 Longbridge｜Terms of Service Privacy Policy

Kenvue

KVUE

19.2400.36% ( -0.070 )

Closed: Jul 31, 16:00:00 (EDT)

OverviewOverview OptionsOptions NewsNews PostsPosts FinancialsFinancials ForecastForecast ValuationValuation ShareholdersShareholders ProfileProfile

LongbridgeAI

Weekly Buzz:CIPLA, VTRS Win FDA Nod; BSX Cuts Jobs; ARGX Snaps Up FBRX; JNJ, GSK Strike Deals
rttnews·1 day ago, 09:53 AM
BNTX-2.44%OTLK-6.10%
Royal Bank of Canada Acquires 3,952,444 Shares of Kenvue Inc. $KVUE
Market Beat·1 day ago, 04:24 AM
KVUE-0.36%RY-0.29%
Kenvue Inc. Stock Falls Thursday, Underperforms Market
MarketWatch Automated·2 days ago, 03:55 PM
KVUE-0.36%
Wall Street Capital Spills Over: Unclassified Plays from AI Cooling to Crypto
Global Report·2 days ago, 04:13 AM
PMEC+1.90%MRNO+1.67%
Kenvue raises quarterly dividend to $0.21 a share
PUBT·Jul 29 at 05:45 AM
KVUE-0.36%
What Are Wall Street Analysts' Target Price for Kenvue Stock?
Barchart Option·Jul 29 at 03:51 AM
KVUE-0.36%
Kenvue Inc. Stock Rises Tuesday, Outperforms Market
MarketWatch Automated·Jul 28 at 03:55 PM
KVUE-0.36%
Kenvue Inc. Stock Rises Monday, Outperforms Market
MarketWatch Automated·Jul 27 at 03:55 PM
KVUE-0.36%
Kenvue’s Tylenol with Naproxen gains FDA approval
Pharmaceutical Business Review·Jul 27 at 04:56 AM
KVUE-0.36%
First Trust Advisors LP Has $49.81 Million Holdings in Kenvue Inc. $KVUE
Market Beat·Jul 27 at 02:38 AM
KVUE-0.36%
Beneath the Mega-Caps: Niche U.S. Equities Prep for H2 2026 Moves
Global Report·Jul 26 at 04:18 AM
FRGT+6.91%NPB+1.27%
Inside Kenvue's Reorganization and Key Moves Across Diverse US Stocks
Global Report·Jul 26 at 04:14 AM
KVUE-0.36%PKE+1.04%
Kenvue (KVUE) Gains FDA Backing As Valuation Questions Return
Simplywall·Jul 26 at 04:09 AM
KVUE-0.36%